DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the TAKE SOLUTIONS LTD (TAKE) share price today?

TAKE SOLUTIONS LTD (TAKE) is trading at ₹19.05 on the NSE, down 4.99% on the day. Source: DocStoX.

What is the PE ratio of TAKE SOLUTIONS LTD?

TAKE SOLUTIONS LTD has a price-to-earnings (PE) ratio of 26.1 in the Healthcare sector.

What is the market capitalisation of TAKE SOLUTIONS LTD?

TAKE SOLUTIONS LTD has a market capitalisation of approximately ₹288 crore.

TAKE SOLUTIONS LTD

TAKE·NSE·Healthcare

₹19.05▼ -1.00 (-4.99%)

Healthcare · Healthcare Technology

Debt-free and consistently profitable

Day₹19.05

₹20.05

52W₹9

₹5025%

Open

₹20.04

High

₹20.05

Low

₹19.05

Prev Close

₹20.05

Volume

1.75L

VWAP

₹19.17

Snapshot

Key fundamentals

Market Cap

₹288 Cr

P/E Ratio

26.10Fair

P/B Ratio

11.18

EPS

₹0.73

Book Value

₹2.10

ROE

16.50%Strong

ROCE

19.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.00Low

Face Value

₹1.00

52W High

₹50.14

52W Low

₹8.88

Sector

Healthcare

Industry

Healthcare Technology

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹4

▼ 80.8%downside

Trading at ₹19 — 81% above our estimate

BearFair valueBull

₹3₹4₹6

/100

Business quality — Watch the fundamentals

Growth 0Profitability 79Efficiency 28Valuation 80

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet
Revenue has been shrinking

Strengths

Virtually debt-free balance sheet

Risks

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

17% ROE fading to 12% over ~10 yrs, on ₹2 book

₹3

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹6

Analyst target

No analyst coverage

—

Blended fair value₹4

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet

Bear case

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

26.1Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

16.5%Strong

Above 15% is considered healthy for Indian equities

ROCE

19.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹288 Cr

P/B

11.18

EPS

₹0.73

Div Yield

—

What changed

Recent changes

Foreign investors-0.3% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 26.1×

Growth

Shrinking

-34% rev CAGR

Profitability

Healthy

16.5% ROE

Financial health

Rock solid

D/E 0.00

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹33.55L Cr

Trades894

VWAP₹19.17

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-34.1%

-41.3%

10Y

-25.5%

Profit

—

10Y

-21.6%

EPS

—

10Y

-22.9%

Profile

Pros

Company is almost debt free.

Watch-outs

Cons

Stock is trading at 10.8 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -41.2% over past five years.
Tax rate seems low
Company has a low return on equity of -47.0% over last 3 years.
Earnings include an other income of Rs.13.3 Cr.
Working capital days have increased from -2,718 days to 123 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.27 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

Promoter

Promoters

0.0%0.00

Public

31.6%-7.21

FII / FPI

0.3%-0.27

DII

0.0%0.00

Total shareholders

64,699-5,625 QoQ

Quarterly trend

Ownership over time

Q4 FY26

FII0.29%

Public31.59%

Others68.12%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]